Lexaria Bioscience(LEXX) - 2020 Q4 - Annual Report
For the fiscal year ended August 31, 2020 10-K 1 lxrp_10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 000-52138 | LEXARIA BIOSCIENCE CORP. | | | --- | --- | | (Exact name of registrant as specified in its charter) | | | ...